ProCorde AG

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

CorFlow Therapeutics

This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.

Cardior Pharmaceuticals

This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.

CorFlow Therapeutics AG

This company develops medical devices for diagnosing and treating microvascular obstruction in heart attack patients for use by interventional cardiologists in catheterisation laboratories.

Protembis

This company develops a cerebral protection system to prevent brain injury and stroke for patients undergoing transcatheter aortic valve replacement and other cardiology procedures.

Corvidia Therapeutics

This clinical-stage biotechnology company develops precision therapies for patients with chronic kidney disease who are at high risk of cardiovascular events.

CoreMedic

This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.